Common use of Study Data Clause in Contracts

Study Data. During the course of the Study, Principal Investigator has agreed to collect certain data, and submit it to CRO, Pfizer or Pfizer’s agent (“Study Data”) as specified in the protocol. Study Data may include Personal Data of Study Subjects. Principal Investigator will ensure accurate and timely collection, recording, and submission of Study Data, including adhering to timelines for data entry set out in the CRF Completion Requirements document provided to Principal Investigator by CRO or Pfizer. Institution will cooperate with Principal Investigator if and as needed to facilitate compliance by Principal Investigator with this obligation. a.

Study Data. During the course of the Study, Principal Investigator has agreed to will collect certain data, data as specified in the Protocol and submit it to CROSPONSOR, Pfizer SPONSOR’s agent, or Pfizer’s agent representative (“Study Data”) as specified in the protocol. Study Data may include Personal Data of Study Subjects). Principal Investigator will ensure accurate and timely collection, recording, and submission of Study Data, including adhering to timelines for data entry set out in the CRF Completion Requirements document or other data entry requirements document provided to Principal Investigator Institution by CRO or Pfizer. Institution will cooperate with Principal Investigator if and as needed to facilitate compliance by Principal Investigator with this obligation. a.SPONSOR.

Study Data. During the course of the Study, Principal Investigator Institution has agreed to collect certain data, and submit it to CRO, Pfizer or Pfizer’s agent (“Study Data”) as specified in the protocol. Study Data may include Personal Data of Study Subjects. Principal Investigator will ensure accurate and timely collection, recording, and submission of Study Data, including adhering to timelines for data entry set out in the CRF Completion Requirements document provided to Principal Investigator by CRO or Pfizer. Institution will cooperate with Principal Investigator if and as needed to facilitate compliance by Principal Investigator with this obligation. a.11.1

Study Data. During the course of the Study, Principal Investigator has agreed to collect certain data, as specified in the Protocol, and submit it to CRO, Pfizer or Pfizer’s agent (“Study Data”) as specified in the protocol. Study Data may include Personal Data of Study Subjects). Principal Investigator will ensure accurate and timely collection, recording, and submission of Study Data, including adhering to timelines for data entry set out in the CRF Completion Requirements document provided to Principal Investigator by CRO or Pfizer. Institution The Health Services Provider will cooperate with Principal Investigator if and as needed to facilitate compliance by Principal Investigator with this obligation. a..

Study Data. During the course of the Study, Principal Investigator has agreed to will collect certain data, as specified in the Protocol, and submit it to CRO, Pfizer or Pfizer’s agent (“Study Data”) as specified in the protocol. Study Data may include Personal Data of Study Subjects). Principal Investigator will ensure accurate and timely collection, recording, and submission of Study Data, including adhering to timelines for data entry set out in the CRF Completion Requirements document provided to Principal Investigator by CRO or Pfizer. Institution will cooperate with Principal Investigator if and as needed to facilitate compliance by Principal Investigator with this obligation. a.timelines